£144.57

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£145 today · all-time low £144 (Sep 2026) · usually £146

Humana Protein Kinase C in Cancer Signaling and Therapy (Current Cancer Research)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 85 days · 85 data points (no recent data)

Historical
Generating forecast…
£146.88 £143.56 £144.28 £145.01 £145.73 £146.46 £147.18 22 August 2026 12 September 2026 03 October 2026 24 October 2026 14 November 2026
View at Amazon ↗

Price data checked 6 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 85 days • 4 price levels

Days at Price
Current Price
16 days 1 day · current 32 days 36 days 0 9 18 27 36 £144 £145 £146 £147 Days at Price

Price Analysis

Most common price: £147 (36 days, 42.4%)

Price range: £144 - £147

Price levels: 4 different prices over 85 days

Description

Protein kinase C (PKC), a family of serine-threonine kinases, rocketed to the forefront of the cancer research field in the early 1980’s with its identification as an effector of phorbol esters, natural products with tumor promoting activity. Phorbol esters had long been of interest to the cancer research field due to early studies in the mouse skin carcinogenesis model, which showed that prolonged topical application of phorbol esters promoted the formation of skin tumors on mice previously treated with mutagenic agents. Research in the last years has established key roles for PKC isozymes in the control of cell proliferation, migration, adhesion, and malignant transformation. In addition, there is a large body of evidence linking PKC to invasion and cancer cell metastasis. Moreover, it is now well established that the expression of PKC isozymes is altered in various types of cancers. More importantly, small molecule inhibitors have been developed with significant anti-cancer activity. The relevance of PKC isozymes in cancer signaling is therefore remarkable. This book will have 4 sections. There will be 23 chapters. Each section will have a brief introduction by an expert in the field (~ 1-2 pages).

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
07 September 2012
Listed Since
14 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Protein Kinase C: Emerging Roles and Therapeutic Potential (Biochemistry Research Trends)
87% match

Protein Kinase C: Emerging Roles and Therapeutic Potential (Biochemistry Research Trends)

£73.87 23 Oct 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
86% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£109.07 23 Oct 2026
Cell Cycle Inhibitors in Cancer Therapy: Current Strategies (Cancer Drug Discovery and Development)
86% match

Cell Cycle Inhibitors in Cancer Therapy: Current Strategies (Cancer Drug Discovery and Development)

Humana

£113.76 16 Nov 2026
Chemokines and Cancer (Contemporary Cancer Research)
85% match

Chemokines and Cancer (Contemporary Cancer Research)

Humana

£128.14 24 Oct 2026
Cell Signaling & Molecular Targets in Cancer
84% match

Cell Signaling & Molecular Targets in Cancer

Springer

£109.62 20 Oct 2026
Cytokines in the Genesis and Treatment of Cancer (Cancer Drug Discovery and Development)
84% match

Cytokines in the Genesis and Treatment of Cancer (Cancer Drug Discovery and Development)

Humana

£148.47 03 Nov 2026
Nutrients in Cancer Prevention and Treatment: 27 (Experimental Biology and Medicine, 27)
84% match

Nutrients in Cancer Prevention and Treatment: 27 (Experimental Biology and Medicine, 27)

Humana

£85.33 03 Nov 2026
Cell Signaling & Molecular Targets in Cancer
83% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 21 Oct 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
83% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£156.70 30 Oct 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
83% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£141.67 02 Nov 2026
Proteases and Cancer: Methods and Protocols: 1731 (Methods in Molecular Biology, 1731)
83% match

Proteases and Cancer: Methods and Protocols: 1731 (Methods in Molecular Biology, 1731)

Humana

£80.65 22 Oct 2026
Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy
83% match

Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy

Springer

£113.76 27 Oct 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
83% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.21 22 Oct 2026
Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)
83% match

Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)

Springer

£108.24 16 Nov 2026
Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)
83% match

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)

Humana

£108.01 23 Oct 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
83% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£76.42 23 Oct 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
83% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£144.51 23 Oct 2026
Management of Castration Resistant Prostate Cancer (Current Clinical Urology)
83% match

Management of Castration Resistant Prostate Cancer (Current Clinical Urology)

Humana

£112.82 14 Nov 2026
STAT Inhibitors in Cancer (Cancer Drug Discovery and Development)
82% match

STAT Inhibitors in Cancer (Cancer Drug Discovery and Development)

Humana

£112.02 31 Oct 2026
Current Cancer Therapeutics
82% match

Current Cancer Therapeutics

Springer

£77.47 16 Oct 2026
Cancer Gene Therapy (Contemporary Cancer Research)
82% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£166.07 24 Oct 2026
Apoptosis, Senescence and Cancer (Cancer Drug Discovery and Development)
82% match

Apoptosis, Senescence and Cancer (Cancer Drug Discovery and Development)

Humana

£171.98 09 Nov 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
82% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£141.86 24 Oct 2026
Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)
82% match

Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£111.28 30 Oct 2026